comparemela.com
Home
Live Updates
Betagenon co-founder publishes that AMPK activator O304 prev
Betagenon co-founder publishes that AMPK activator O304 prev
Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice
/PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Helena...
Related Keywords
Sweden ,
Stockholm ,
James Hall ,
Alice Wallenbergs Stiftelse ,
Familjen Erling Perssons ,
Helena Edlund ,
Centre For Molecular Medicine ,
Scientific Reports ,
Molecular Medicine ,
Heart Failure ,
Renal Disease ,
Betagenon Ab ,